NKIRAS1
Basic information
Region (hg38): 3:23889951-23946591
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NKIRAS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 14 | 0 | 0 |
Variants in NKIRAS1
This is a list of pathogenic ClinVar variants found in the NKIRAS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-23890535-A-G | not specified | Uncertain significance (Sep 09, 2024) | ||
3-23890542-A-G | not specified | Uncertain significance (Oct 13, 2021) | ||
3-23893163-G-A | not specified | Uncertain significance (Jul 10, 2024) | ||
3-23893169-A-C | not specified | Uncertain significance (Oct 22, 2024) | ||
3-23893219-G-C | not specified | Uncertain significance (Nov 15, 2024) | ||
3-23893297-T-C | not specified | Uncertain significance (Oct 04, 2024) | ||
3-23893331-T-A | not specified | Uncertain significance (Jun 23, 2023) | ||
3-23900831-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
3-23900906-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
3-23900972-G-A | not specified | Uncertain significance (Aug 21, 2024) | ||
3-23901014-T-C | not specified | Uncertain significance (Aug 31, 2022) | ||
3-23901022-T-C | not specified | Uncertain significance (Jan 10, 2023) | ||
3-23901035-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
3-23910849-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
3-23917732-A-C | Likely benign (Dec 21, 2018) | |||
3-23917766-T-C | Likely benign (Aug 09, 2018) | |||
3-23917859-G-C | not specified | Uncertain significance (Jan 03, 2019) | ||
3-23917877-C-T | RPL15-related disorder | Likely benign (Sep 20, 2023) | ||
3-23917882-A-C | Uncertain significance (May 18, 2023) | |||
3-23917888-T-C | Diamond-Blackfan anemia 12 | Pathogenic (May 18, 2023) | ||
3-23917904-G-A | Likely benign (Jun 06, 2023) | |||
3-23917906-C-G | Uncertain significance (Sep 19, 2022) | |||
3-23917907-T-A | Likely benign (Jul 26, 2023) | |||
3-23917914-A-G | Uncertain significance (Jul 19, 2022) | |||
3-23917934-C-G | not specified • RPL15-related disorder | Benign/Likely benign (Jan 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NKIRAS1 | protein_coding | protein_coding | ENST00000443659 | 3 | 54932 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000501 | 0.699 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.879 | 74 | 98.5 | 0.751 | 0.00000485 | 1252 |
Missense in Polyphen | 20 | 32.151 | 0.62206 | 400 | ||
Synonymous | 0.132 | 36 | 37.0 | 0.972 | 0.00000196 | 359 |
Loss of Function | 0.833 | 6 | 8.64 | 0.694 | 4.48e-7 | 107 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000207 | 0.000207 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000264 | 0.000264 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000294 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Atypical Ras-like protein that acts as a potent regulator of NF-kappa-B activity by preventing the degradation of NF-kappa-B inhibitor beta (NFKBIB) by most signals, explaining why NFKBIB is more resistant to degradation. May act by blocking phosphorylation of NFKBIB and mediating cytoplasmic retention of p65/RELA NF-kappa-B subunit. It is unclear whether it acts as a GTPase. Both GTP- and GDP-bound forms block phosphorylation of NFKBIB. {ECO:0000269|PubMed:10657303, ECO:0000269|PubMed:12672800, ECO:0000269|PubMed:15024091}.;
- Pathway
- Toll Like Receptor 7/8 (TLR7/8) Cascade;Signaling by Interleukins;Cytokine Signaling in Immune system;Toll Like Receptor 9 (TLR9) Cascade;MyD88 cascade initiated on plasma membrane;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;ZBP1(DAI) mediated induction of type I IFNs;Toll-Like Receptors Cascades;TRAF6 mediated NF-kB activation;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interleukin-1 signaling;Innate Immune System;Immune System;RIP-mediated NFkB activation via ZBP1;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;TNFalpha;Cytosolic sensors of pathogen-associated DNA ;TRIF(TICAM1)-mediated TLR4 signaling ;MyD88-independent TLR4 cascade ;Toll Like Receptor 4 (TLR4) Cascade;MyD88:Mal cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll Like Receptor 2 (TLR2) Cascade;Interleukin-1 family signaling
(Consensus)
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- 0.724
- rvis_EVS
- -0.08
- rvis_percentile_EVS
- 47.79
Haploinsufficiency Scores
- pHI
- 0.121
- hipred
- Y
- hipred_score
- 0.796
- ghis
- 0.639
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.952
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nkiras1
- Phenotype
Gene ontology
- Biological process
- I-kappaB kinase/NF-kappaB signaling
- Cellular component
- cellular_component;cytoplasm;membrane
- Molecular function
- GTPase activity;GTP binding